Welcome to our dedicated page for Selectquote news (Ticker: SLQT), a resource for investors and traders seeking the latest updates and insights on Selectquote stock.
SelectQuote Inc (SLQT) operates a leading technology-driven insurance distribution platform, providing consumers with unbiased comparisons across life, senior, and property insurance products. This news hub offers investors and industry observers centralized access to official updates and strategic developments from the commission-based innovator.
Track key announcements including quarterly earnings, carrier partnerships, and technology initiatives that shape the company's position in insurance markets. The curated news collection serves as a reliable resource for understanding operational milestones across SelectQuote's core segments: Senior, Healthcare Services, Life, and Auto & Home insurance.
Discover updates on leadership changes, regulatory compliance developments, and product expansion efforts that demonstrate SelectQuote's commitment to simplifying insurance access through its agent-supported platform. Content is rigorously verified to ensure accuracy and relevance for both professional analysts and casual observers.
Bookmark this page for streamlined access to SelectQuote's evolving business narrative. Check regularly for neutral, factual reporting on how the company continues leveraging technology to transform insurance shopping experiences while maintaining partnerships with highly-rated carriers.
SelectQuote (NYSE: SLQT) reported a fourth-quarter revenue of $139.4 million, down from $185.3 million a year prior. The company experienced a net loss of $104.7 million, compared to a net income of $0.8 million in Q4 2021. Adjusted EBITDA was $(60.8) million versus $18.1 million the previous year. For fiscal year 2023, revenue guidance is projected between $850 million and $950 million, with net losses expected to range from $113 million to $89 million.
SelectQuote, Inc. (NYSE: SLQT) has appointed Alan Muney, MD, as part-time Chief Medical Officer and Simeon Schindelman as Senior Executive Healthcare Advisor. Dr. Muney brings over 35 years of experience from Cigna and aims to enhance healthcare strategy, focusing on member engagement and clinical quality. Schindelman, a healthcare veteran, will develop innovative solutions across healthcare channels. These appointments are expected to strengthen SelectQuote's healthcare services and improve operational effectiveness, helping the company grow its business in a competitive market.
SelectQuote, Inc. (NYSE: SLQT) is in advanced talks with lenders to amend its credit agreement, ensuring continued compliance with debt covenants. The company plans to release its fiscal Q4 and full-year 2022 results on August 29, 2022, before market opening. CEO Tim Danker and Interim CFO Ryan Clement will hold a conference call at 8:30 am ET the same day to discuss the results. Notably, a definitive agreement with lenders is expected by that date.
SelectQuote, Inc. (NYSE: SLQT) will release its fiscal fourth quarter and full year 2022 financial results on August 18, 2022, before market open. CEO Tim Danker and Interim CFO Ryan Clement will discuss the results during a conference call at 8:30 am ET on the same day. The call will be accessible via registration, ensuring attendees receive dial-in information. SelectQuote, founded in 1985, specializes in unbiased insurance comparisons and operates in three core segments: Senior, Life, and Auto & Home, focusing on protecting consumer assets.
SelectQuote, Inc. (NYSE: SLQT) announces the departure of CFO Raff Sadun after five years, effective at the end of the month. Ryan Clement, SVP of Financial Planning & Analysis, will serve as interim CFO during the search for a permanent replacement. Sadun played a key role during the company’s IPO in 2020 and contributed significantly to its finance function. CEO Tim Danker expressed gratitude for Sadun's contributions to the company's growth. SelectQuote specializes in insurance solutions and has expanded its operations in recent years, including healthcare services.
SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue of $275.1 million for Q3 FY2022, an increase from $265.3 million in Q3 FY2021. The company experienced a net loss of $6.4 million compared to a net income of $35.2 million in the prior year. Adjusted EBITDA was $13.0 million, down from $63.6 million year-over-year. The company maintained its full-year guidance for revenue, expecting between $810 million and $850 million with a net loss range of $255 million to $236 million.
SelectQuote (NYSE: SLQT) will announce its fiscal Q3 2022 financial results on May 5, 2022, before market opening. CEO Tim Danker and CFO Raff Sadun will discuss the results in a conference call at 8:30 AM ET the same day. SelectQuote, established in 1985, offers unbiased insurance comparisons from reputable carriers, helping consumers protect their families and assets. It operates through three main divisions: Senior, Life, and Auto & Home. The company is focused on serving a rapidly aging demographic, particularly in Medicare-related services.
SelectQuote, Inc. (NYSE: SLQT) has formed a strategic partnership with a leading hearing benefits provider to launch the SelectHearing program. This initiative aims to provide affordable hearing healthcare and hearing aid options to members of Population Health. The partnership aligns with recent FDA efforts to enhance access to hearing aids, addressing untreated hearing loss which has been linked to significantly higher healthcare costs. The program is expected to improve health outcomes for consumers, particularly among older adults who often experience hearing limitations.
SelectQuote (NYSE: SLQT) has established a new Healthcare Advisory Board to enhance its Population Health strategy. This board comprises experts from various healthcare sectors, aimed at improving consumer engagement and reducing healthcare costs. Notable members include Dr. Kavita Patel and Earl Devanny, along with several distinguished professionals from the healthcare domain. The board will provide strategic insights and recommendations to strengthen Population Health services, signaling a commitment to innovation and better health outcomes.
SelectQuote, Inc. (SLQT) reported a consolidated revenue of $195.0 million for Q2 FY2022, down from $357.6 million in the same quarter last year. The company faced a net loss of $137.0 million, compared to a net income of $89.9 million a year ago. Adjusted EBITDA was $(163.3) million. Full-year guidance expects revenue between $810 million to $850 million and a net loss of $255 million to $236 million. The Senior segment experienced a notable decline in revenue and profitability due to market challenges.
FAQ
What is the current stock price of Selectquote (SLQT)?
What is the market cap of Selectquote (SLQT)?
